[
WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA
[og_img]
https://www.investing.com/news/press-releases/wuxi-biologics-congratulates-partner-canbridge-pharmaceuticals-on-the-approval-of-innovative-velaglucerasebeta-for-injection-gaurunning-for-gaucher-disease-by-china-nmpa-93CH-4051513
Investing.com
WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA
Related articles